Stay updated on Safety of HSC835 in Hematological Malignancies Clinical Trial
Sign up to get notified when there's something new on the Safety of HSC835 in Hematological Malignancies Clinical Trial page.

Latest updates to the Safety of HSC835 in Hematological Malignancies Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.3.4 is now shown and Revision: v3.3.3 is removed. This appears to be a template/version-tracking update and does not alter study data or user-facing content.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedMinnesota was added as a study location under Locations, and the page revision was updated from v3.3.2 to v3.3.3. The HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page footer shows a new revision label (Revision: v3.3.2) and the previous label (v3.2.0) is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedA government funding/operating status notice has been removed from the page. The core study details, eligibility criteria, and results-related information remain unchanged.SummaryDifference0.4%

- Check79 days agoChange DetectedThe screenshots show cosmetic UI updates and refreshed metadata while core study data such as enrollment numbers, status, eligibility, and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check107 days agoChange DetectedAdded a government-operating-status notice and a version update to v3.2.0; removed several disease names and the prior revision tag v3.1.0.SummaryDifference5%

Stay in the know with updates to Safety of HSC835 in Hematological Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of HSC835 in Hematological Malignancies Clinical Trial page.